LAUSR

Study Objective Although hysteroscopy can be used for assessing the uterine cavity in women with suspected, endometrial cancer, it remains controversial as a procedure that can enhance metastasis spread. Endometrial cells may shed during hysteroscopy and be passively transported with fluid into the peritoneal cavity. Moreover, it is important to assess this hypothesis into type 2 endometrial cancer, a more aggressive phenotype that usually presents with endometrial atrophy and worse prognosis. Thus, we aimed to assess the prevalence of positive peritoneal cytology in type II endometrial cancer in women undergoing hysteroscopy as a diagnostic tool and determine their prognosis. Design Retrospective cohort analysis (2002-2017). Setting Tertiary, academic hospital. Patients or Participants 127 women with type II endometrial cancer. Interventions Diagnostic hysteroscopy (HSC)(n=43) or dilation/curettage (DCp Conclusion Diagnostic HSC did not increase the rate of positive peritoneal cytology at the time of surgical staging in this cohort of women with type II endometrial cancer and presented equal safety when compared to D&C.